0001209191-16-099585.txt : 20160217
0001209191-16-099585.hdr.sgml : 20160217
20160217202006
ACCESSION NUMBER: 0001209191-16-099585
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160215
FILED AS OF DATE: 20160217
DATE AS OF CHANGE: 20160217
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENOMIC HEALTH INC
CENTRAL INDEX KEY: 0001131324
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 770552594
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-556-9300
MAIL ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Popovits Kimberly J
CENTRAL INDEX KEY: 0001333482
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51541
FILM NUMBER: 161435731
MAIL ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-02-15
0
0001131324
GENOMIC HEALTH INC
GHDX
0001333482
Popovits Kimberly J
301 PENOBSCOT DR.
REDWOOD CITY
CA
94063
1
1
0
0
President and CEO
Common Stock
2016-02-15
4
F
0
3195
26.53
D
32496
D
Common Stock
2016-02-16
4
A
0
26300
0.00
A
58796
D
Common Stock
16825
I
Held in trust for the benefit of Ms. Popovits' son, of which Ms. Popovits is trustee.
Common Stock
12298
I
Held by UBS for Benefit of Kimberly Popovits
Common Stock
203001
I
Held by the Popovits 2010 Trust
Employee Stock Option (right to buy) Holding
27.00
2016-02-16
4
A
0
153860
0.00
A
2026-02-16
Common Stock
153860
153860
D
Includes an aggregate of 4,334 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
Restricted stock units awarded on February 16, 2016 which vest as to 1/3 of the shares on each of February 15, 2017, 2018 and 2019.
Includes an aggregate of 30,634 shares of common stock issuable pursuant to restricted stock units that have not vested.
The option becomes exercisable as to 25% of the shares on February 16, 2017, and becomes exercisable as to 1/48th of the shares each full month thereafter.
/s/ Jason W. Radford, Attorney-in-fact
2016-02-17